Related references
Note: Only part of the references are listed.Opioid agonist - tachykinin antagonist as a new analgesic with adjuvant anticancer properties
Joanna Matalinska et al.
FOLIA NEUROPATHOLOGICA (2013)
Continuous Subcutaneous Instillation of Bupivacaine Compared to Saline Reduces Interleukin 10 and Increases Substance P in Surgical Wounds After Cesarean Delivery
Brendan Carvalho et al.
ANESTHESIA AND ANALGESIA (2010)
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance
T. M. Largent-Milnes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision
Peyman Sahbaie et al.
PAIN (2009)
Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery
Brendan Carvalho et al.
JOURNAL OF PAIN (2008)
Sustained Inhibition of Neurotransmitter Release from Nontransient Receptor Potential Vanilloid Type 1-Expressing Primary Afferents by μ-Opioid Receptor Activation-Enkephalin in the Spinal Cord
Hong-Yi Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The effect of substance P on nitric oxide release in a rheumatoid arthritis model
M. C. O'Shaughnessy et al.
INFLAMMATION RESEARCH (2006)
A role for substance P in arthritis?
JE Keeble et al.
NEUROSCIENCE LETTERS (2004)
Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons
KJ Powell et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Share Paper
